May 8 (Reuters) - Zynerba Pharmaceuticals Inc:
* ZYNERBA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
* ZYNERBA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.91
* ZYNERBA - BELIEVES CASH, CASH EQUIVALENT POSITION OF $52.1 MILLION AS OF MARCH 31, IS SUFFICIENT TO FUND OPERATIONS, CAPITAL REQUIREMENTS INTO 2019 Source text: (bit.ly/2IqdNOw) Further company coverage: (Reuters.Briefs@thomsonreuters.com)